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Abstract Aquaporin-4 (AQP4) is a water-channel protein
expressed strongly in the brain, predominantly in astrocyte
foot processes at the borders between the brain parenchyma
and major fluid compartments, including cerebrospinal
fluid (CSF) and blood. This distribution suggests that
AQP4 controls water fluxes into and out of the brain
parenchyma. Experiments using AQP4-null mice provide
strong evidence for AQP4 involvement in cerebral water
balance. AQP4-null mice are protected from cellular
(cytotoxic) brain edema produced by water intoxication,
brain ischemia, or meningitis. However, AQP4 deletion
aggravates vasogenic (fluid leak) brain edema produced by
tumor, cortical freeze, intraparenchymal fluid infusion, or
brain abscess. In cytotoxic edema, AQP4 deletion slows the
rate of water entry into brain, whereas in vasogenic edema,
AQP4 deletion reduces the rate of water outflow from brain
parenchyma. AQP4 deletion also worsens obstructive
hydrocephalus. Recently, AQP4 was also found to play a
major role in processes unrelated to brain edema, including
astrocyte migration and neuronal excitability. These find-
ings suggest that modulation of AQP4 expression or
function may be beneficial in several cerebral disorders,
including hyponatremic brain edema, hydrocephalus,
stroke, tumor, infection, epilepsy, and traumatic brain
injury.
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Introduction
The aquaporins (AQPs) are a family of water-channel
proteins. The first AQP was identified in red blood cells
in 1991 and called AQP1 [1]. Over the last 15 years, at
least 13 AQPs have been discovered in mammals. The
aquaporins are tetramers, each monomer having its own
water pore. AQPs primarily transport water, except for
AQP3, AQP7, and AQP9, the aquaglyceroporins, which
also transport glycerol and various small polar molecules.
Here we review the mechanisms of brain edema formation
and absorption and discuss newly discovered roles of
AQP4.
Aquaporins in nonbrain tissues Analysis of transgenic
mice lacking specific AQPs has provided insight into the
physiological roles of AQPs (reviewed in [2]). Mice
lacking several AQPs (AQPs 1–4) manifest a defect in
urinary concentrating ability [3]. Near-isosmolar fluid
secretion is impaired in salivary and airway submucosal
gland in AQP5 deficiency. The general paradigm from
these findings is that high transepithelial water permeability
permits rapid water transport in response to active trans-
epithelial salt transport. AQP deletion impairs osmotic
equilibration, resulting in reduced volume of relatively
hypertonic fluid secretion (Fig. 1a). A second mechanism
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for involvement of AQPs in mammalian physiology is
facilitation of passive, osmotically driven water transport,
as in osmotic water extraction in kidney collecting duct
(Fig. 1b). As discussed below with regard to astrocytes, a
newly discovered role of AQPs is cell migration facilita-
tion. We propose that the mechanism for this facilitation is
that actin cleavage and ion uptake at the tip of a
lamellipodium create local osmotic gradients that drive
water influx (Fig. 1c).
The aquaglyceroporins have unique biological roles
related to their glycerol transport function. AQP3-facilitated
glycerol transport in skin is an important determinant of
epidermal and stratum corneum hydration. AQP3 is
expressed strongly in the basal layer of keratinocytes in
mammalian skin. Mice lacking AQP3 have reduced stratum
corneum hydration and skin elasticity and impaired stratum
corneum biosynthesis and wound healing. The mechanism
responsible for the skin phenotype in AQP3 deficiency
involves reduced epidermal-cell skin glycerol permeability,
resulting in reduced glycerol content in the stratum
corneum and epidermis (Fig. 1d). Another aquaglycer-
oporin, AQP7, is expressed in the plasma membrane of
adipocytes. AQP7-null mice have a greater fat mass than
do wild-type mice as they age, with remarkable adipocyte
hypertrophy and accumulation of glycerol and triglycerides.
Hypertrophy of AQP7-deficient adipocytes probably results
from reduced plasma membrane glycerol permeability and
consequent increased glycerol accumulation and triglyceride
biosynthesis (Fig. 1e).
Aquaporins in brain AQP4 is the primary water channel
found in the brain, but AQP1 and AQP9 have also been
reported. In this review, we concentrated on AQP4, which
is much more abundantly expressed in brain than is AQP1
or AQP9. AQP1 is expressed in the choroid plexus and
plays a role in cerebrospinal fluid (CSF) formation [4].
AQP9 protein has been detected weakly by antibody
staining by some groups in some astrocytes processes at
the glia limitans [5] and in ependymal cells and tanycytes
[6].
AQP4 expression AQP4 expression, studied using immuno-
histochemistry and immunoelectron microscopy, was
found in glia only. AQP4 is expressed in astrocyte foot
processes surrounding capillaries, astrocyte processes com-
prising the glial limiting membrane, in ependymal cells,
and in subependymal astrocytes [7, 8]. Although AQP4 is
also expressed in the supraoptic and suprachiasmatic nuclei
of the hypothalamus, AQP4-null mice do not have
hypothalamic disturbances [9]. The pattern of AQP4
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Fig. 1 Mechanisms of aquaporin (AQP) function outside the brain.
a Reduced water permeability in glandular epithelium impairs active,
near-isosmolar fluid transport by slowing osmotic water transport into
the acinar lumen, producing hypertonic secretion. b Reduced trans-
epithelial water permeability in kidney collecting duct impairs urinary
concentrating ability by preventing osmotic equilibration of luminal
fluid. c AQP-facilitated water entry into protruding lamellipodia,
accounting for AQP-dependent cell migration. d Reduced steady-state
glycerol content in epidermis and stratum corneum following AQP3
deletion, accounting for reduced skin hydration in AQP3 deficiency.
e Impaired AQP7-dependent glycerol escape from adipocytes, result-
ing in intracellular glycerol accumulation and increased triglyceride
content accounting for progressive adipocyte hypertrophy in AQP7
deficiency
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protein expression, predominantly at the borders between
the brain parenchyma and major fluid compartments,
suggests involvement of AQP4 in water movement into
and out of the brain parenchyma.
The mechanisms described below are based on experi-
ments involving adult mice. Because the pattern of
expression of aquaporins in human brain is similar to that
of the mouse brain, these mechanisms probably apply to
humans, also. However, little is known about edema
formation and absorption in neonates. Neonates have less
prominent AQP4 expression in the brain [10], immature
blood–brain [11, 12] and blood–CSF [13] barriers, and
increased extracellular space volume [14]. These differ-
ences between the neonate and adult brain may be
important, and therefore, mechanisms of edema formation
and elimination may be different.
Brain edema
Brain edema is brain swelling that occurs due to the
accumulation of excess water in the brain parenchyma
[15, 16]. Brain edema is associated with several brain
pathologies, such as hydrocephalus, traumatic brain injury,
stroke, and brain tumors, as well as extracranial pathologies
that affect the brain secondarily, including hyponatremia,
organ failure (liver, kidney), and sepsis. Brain edema is also
seen in globally important systemic infections that primarily
involve the brain, such as childhood cerebral malaria and
meningitis.
Brain water homeostasis In the normal adult brain, water is
distributed between several compartments, including CSF
(CSF, ~75–100 ml), blood (~75–100 ml) and intracellular
(1,100–1,300 ml) and interstitial (~100–150 ml) brain
parenchyma. Water moves between the different compart-
ments in response to osmotic gradients and hydrostatic
pressure differences. Because the brain is enclosed in a
rigid skull, brain swelling produces displacement of water
from low-pressure compartments, including CSF and
venous blood (~10 mmHg), into peripheral blood. Once
the low-pressure reserve is exhausted, intracranial pressure
progressively rises; the sulci become effaced on computed
tomography (CT) and magnetic resonance image (MRI)
scans, then the third ventricle becomes invisible, and finally
the basal cisterns disappear due to brain-stem herniation.
High intracranial pressure can therefore cause brain
ischemia, herniation, and death. This scenario, however, does
not apply to young children (less than a year old) in whom
the open fontanelles can accommodate, to some extent,
the swollen brain. In this situation, the fontanelles bulge
and the head circumference increases, minimizing the rise in
intracranial pressure. However, even the open fontanelles
cannot compensate for rapid brain swelling, and therefore,
young children are not fully resistant to the development of
high intracranial pressure and brain herniation.
Brain edema management Brain edema management
includes sedation and avoidance of hypercapnia to prevent
intracranial pressure elevation, administration of intrave-
nous hyperosmolar solutions such as mannitol and hyper-
tonic saline, corticosteroids for brain tumors, surgical
resection of the causative lesion, and in extreme cases,
decompressive craniectomy. For critically ill patients,
invasive monitoring of intracranial pressure and cerebral
perfusion pressure is done to optimize therapy. However,
many of these therapies to reduce brain swelling were
introduced early in the early/mid twentieth century, and
their efficacy is limited [17, 18]. The paucity of effective
drugs to be used in brain edema reflects, in part, the
incomplete understanding of cellular mechanisms involved
in brain edema formation and resolution.
Edema formation mechanisms A logical framework for
understanding the cellular mechanisms of brain edema was
first suggested by Igor Klatzo in the 1960s, when he
classified edema into cytotoxic and vasogenic types; a third
type, termed hydrocephalic edema, has subsequently been
described [15]. Common causes of brain edema are
summarized in the Table 1.
Cytotoxic edema, as seen in hyponatremia and early
cerebral ischemia, is intracellular accumulation of water
due to energy failure and inability of cells to regulate their
volume [16]. This results in a shift of water from the
interstitial into the intracellular compartment and a net
uptake of water from the blood compartment into the brain
parenchyma. Astrocytes are the main cell type that swell in
cytotoxic brain edema, especially the pericapillary foot
processes [16], which are the predominant sites of AQP4
expression in the brain [8, 19]. Astrocyte swelling may be
an important early event predisposing the brain to further
damage. Because cytotoxic edema affects all cells, both
gray and white matter swell, resulting in loss of the clear
margin between gray and white matter on CT and MRI
scans. Because the blood–brain barrier is intact, excess
brain water is not accompanied by protein, and there is no
brain enhancement on CT or MRI scans after intravenous
contrast administration.
Vasogenic edema, of which brain tumor and brain
abscess edema are prime examples, involves disruption of
the blood–brain barrier. As a result, iso-osmotic fluid and
serum proteins enter the interstitial space from the
bloodstream in response to a hydrostatic pressure differ-
ence. Therefore, in vasogenic brain edema, there is
expansion of the interstitial space [20]. The resistance to
flow of interstitial fluid is higher in gray matter (consisting
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of tangles of cell processes) compared with white matter
(primarily consisting of aligned neuronal tracts), which
explains why vasogenic edema fluid is found in the white
matter on CT and MRI. Because the blood–brain barrier is
open, vasogenic brain edema is associated with enhance-
ment of the causative lesion (such as brain tumor) on CT or
MRI scans after intravenous contrast administration.
Hydrocephalic edema refers to movement of CSF from
the ventricles across the ependyma into the interstitial space
in hydrocephalus. This type of brain edema has limited
clinical significance other than providing evidence of
hydrocephalus in situations where ventricular enlargement
is unclear.
Despite the success of the Klatzo classification system,
most clinical conditions consist of mixtures of different
types of edema occurring with different time courses. For
example, early cerebral ischemia produces cell swelling,
but later on, when the capillary endothelium becomes
damaged, the blood–brain barrier is disrupted, resulting in
vasogenic-type swelling.
Edema fluid elimination The mechanisms of edema fluid
clearance are less well understood than the mechanisms of
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Fig. 2 Routes of water exit
from the brain in brain edema.
In both cytotoxic and vasogenic
types of brain edema, excess
fluid is eliminated through
aquaporin-4 (AQP4) rich bar-
riers: a The glia limitans externa
into the subarachnoid space;
b the blood–brain barrier into
the bloodstream; c the glia
limitans interna and ependyma
into the ventricles
Table 1 Some causes of brain
edema Cytotoxic Vasogenic Hydrocephalic
Vascular Brain tumor Obstructive
Early hypoxia Supratentorial Tumor
Early ischemia Infratentorial Aqueduct stenosis
Chiari malformation
Dandy-Walker
Infection Infection Communicating
Cerebral malaria Meningitis Meningitis
Meningitis Abscess Subarachnoid hemorrhage
Intraventricular hemorrhage
Metabolic
Hyponatremia Traumatic
Hyperammonemia
Diabetic ketoacidosis Vascular
Hyperbilirubinemia Late hypoxia
Uremic Late ischemia
Traumatic
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edema fluid formation. In all brain edema types, excess
fluid leaves the brain parenchyma along three different
routes: across the blood–brain barrier into the bloodstream,
across the ependyma into the ventricles, and across the glia-
limiting membrane into the CSF in the subarachnoid space
(Fig. 2). CSF eventually enters the arachnoid granulations
and is cleared into the superior sagittal venous sinus.
The relative contributions of the three major routes of
edema fluid elimination from the brain are not known. It
has been suggested that vasogenic edema fluid is cleared
primarily by bulk flow through the extracellular space and
across the glia limitans into the CSF [21]. This idea is based
on old experiments that measured clearance rates of inert
dyes injected into brain extracellular space. The dyes were
primarily eliminated into the CSF at equal rates indepen-
dent of molecular weight, favoring a bulk-flow mechanism
[21]. A major flaw with this interpretation is the unjustified
assumption that dye and water efflux routes are identical.
b
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Fig. 3 Aquaporin-4 (AQP4) null mice are protected from hypona-
tremic brain swelling. a Improved survival of AQP4-null (AQP4−/−)
mice compared with wild-type (AQP4+/+) mice following water
intoxication produced by injecting 0.2 ml/g body weight intra-
peritoneally. b Transmission electron micrograph showing edematous
cerebral cortex at 30 min. Note the swollen astrocytic foot process in
brains from AQP4+/+ (black arrows) and AQP4−/− (white arrows)
mice. Scale bar represents 3 μm
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Fig. 4 Aquaporin-4 (AQP4) deletion worsens ventricular enlarge-
ment in hydrocephalus. a Coronal brain sections showing ventricle
size in a normal mouse (top) and in a mouse with obstructive
hydrocephalus (bottom) produced by kaolin injection into the cisterna
magna. b Lateral ventricle size in wild-type (AQP4+/+) and AQP4-
null (AQP4−/−) mice following kaolin injection
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More recent data suggest that excess brain water elimina-
tion in vasogenic edema across the glia limitans involves a
transcellular route, not bulk flow [22].
Death of neurons and glia in cytotoxic edema releases their
intracellular contents into the extracellular space. Regulatory
volume decrease is an interesting phenomenon whereby
swollen cells release intracellular ions (mainly K+ and Cl−)
and amino acids (such as taurine and glutamate) into the
extracellular space [16]. This produces a decrease in cell
size toward baseline. It is possible, then, that in cytotoxic
edema, the excess water initially resides in the intracellular
compartment but ultimately moves to the extracellular space
due to cell death and regulatory volume decrease. Therefore,
excess water elimination routes in cytotoxic edema may be
the same as those in vasogenic edema.
AQP4 and brain edema
AQP4 in cytotoxic edema The first evidence that AQP4
plays a major role in cytotoxic brain edema came from
studies with AQP4-null mice [23]. Intraperitoneal water
injection causes profound hyponatremia to 105 mM within
5 min and subsequent death from brain swelling and
increased intracranial pressure. Mortality after hyponatre-
mia is markedly reduced in AQP4-null mice (Fig. 3). This
protection is associated with reduced blood–brain barrier
water permeability and reduced rate of water flow into the
brain parenchyma. AQP4-null mice are also protected from
other models of cytotoxic brain edema, including bacterial
meningitis [23] and early focal cerebral ischemia [24].
AQP4 protein in plasma membranes is thought to be bound
on an aggregate of intracellular proteins, including α-
syntrophin [25]. Interestingly, α-syntrophin-null mice are
also protected from cytotoxic brain edema produced by
focal cerebral ischemia [26]. Taken together, these findings
suggest that drugs that inhibit AQP4 expression or function
might limit cytotoxic brain swelling in humans.
AQP4 in vasogenic edema An unexpected role for AQP4 in
vasogenic brain edema was shown using three models of
vasogenic brain edema in mice [22]. AQP4 null mice had
more brain swelling compared with wild-type mice after
cortical freeze injury and brain tumor implantation. The
observation that intraparenchymal infusion is eliminated
more slowly in AQP4-null mice compared with wild-type
mice suggests that excess brain water elimination in vaso-
genic edema is defective after AQP4 deletion. Once the
excess interstitial fluid (vasogenic edema) reaches the barriers
between brain parenchyma and fluid compartments, it must be
eliminated by a transcellular AQP4-dependent route. These
findings suggest that AQP4 activators or upregulators, when
available, may reduce vasogenic brain edema in humans.
AQP4 in hydrocephalic edema Hydrocephalus is the accu-
mulation of CSF with ventricular enlargement due to
obstruction in CSF flow (obstructive or noncommunicating
hydrocephalus) or impaired CSF absorption (communicating
hydrocephalus). Causes of obstructive hydrocephalus can be
congenital, e.g., aqueduct stenosis preventing CSF flow from
the third to the fourth ventricle; or acquired, such as brainstem
glioma or intraventricular hematoma. Communicating hydro-
cephalus is often associated with damage to the arachnoid
granulations, as in meningitis. In a model of obstructive
hydrocephalus produced by injecting kaolin in the cisterna
magna of mice, AQP4-null mice had accelerated ventricular
enlargement progression compared with wild-type mice
(Fig. 4) [27]. Presumably, the reduced water permeability
of the ependymal layer, subependymal astrocytes, and glia
limitans produced by AQP4 deletion reduces the elimination
rate of CSF across these borders into the subarachnoid space.
Other functions of AQP4 in the brain Apart from its role in
brain edema, AQP4 was found to a play major role in cell
migration [28–31] and neural excitability. Astrocyte migra-
tion is delayed in AQP4-null mice, and as a result, glial
scarring is impaired [29, 31]. AQP4 is thought to accelerate
astrocyte migration by facilitating transmembrane water
flow, which accompanies the fast changes in cell shape that
occur during migration. Several lines of evidence show
reduced neural excitability in AQP4 deletion: AQP4-null
mice have a higher seizure threshold and prolonged seizure
duration than do wild-type mice [32, 33], and they have
sensorineural deafness [34] and mild retinal impairment
[35]. The mechanism by which AQP4 influences neural
excitability is unknown but may involve interaction
between AQP4 and an astrocytic potassium channel
(Kir4.1) [36], or altered extracellular space size [37].
Conclusion
In children, the main type of brain edema is cytotoxic due to
fluid and electrolyte disturbances. However, vasogenic
edema, as in brain tumors, is seen occasionally. AQP4 is
important in the pathophysiology of cytotoxic and vaso-
genic brain edema, although it has opposing roles. Early on
in cytotoxic edema, AQP4 facilitates edema fluid forma-
tion. In vasogenic brain edema, AQP4 increases the rate of
edema fluid elimination. Therefore, AQP4 inhibitors are
expected to protect the brain in cytotoxic edema, whereas
AQP4 activators or upregulators would be required to
facilitate the clearance of vasogenic brain edema. Unfortu-
nately, there are no known activators or inhibitors of AQP4,
but small-molecule discovery efforts are being directed
toward that discovery.
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